Sunzen Biotech Bhd Capital Reinvestment Ratio
Sunzen Biotech Bhd capital reinvestment ratio. Sunzen Biotech Bhd (0148) has a Capital Reinvestment Ratio of 0.03x as of September 2023, meaning it reinvests 0% of its operating cash flow (RM3.58 Million) in capital expenditures (RM95.00K). Check Sunzen Biotech Bhd (0148) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sunzen Biotech Bhd (2016–2023)
Capital reinvestment ratio of Sunzen Biotech Bhd from 2016 to 2023. This chart tracks Sunzen Biotech Bhd's Capital Reinvestment Ratio across 4 annual periods. Also explore Sunzen Biotech Bhd (0148) equity growth momentum to track the company's year-over-year net asset growth rate.
Sunzen Biotech Bhd Capital Reinvestment Ratio by Year (2016–2023)
Sunzen Biotech Bhd capital reinvestment ratio by year from 2016 to 2023. For the full cash flow conversion analysis, see 0148 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.23x | RM819.39K | RM1.01 Million | ▲ +667.0% |
| 2020 | 0.16x | RM7.20 Million | RM1.16 Million | ▼ -81.1% |
| 2017 | 0.85x | RM4.02 Million | RM3.42 Million | ▼ -96.7% |
| 2016 | 25.91x | RM256.13K | RM6.64 Million | — |